Market Cap 17.95B
Revenue (ttm) 7.68B
Net Income (ttm) 903.70M
EPS (ttm) N/A
PE Ratio 11.13
Forward PE 11.02
Profit Margin 11.77%
Debt to Equity Ratio 0.64
Volume 2,226,100
Avg Vol 1,725,418
Day's Range N/A - N/A
Shares Out 198.18M
Stochastic %K 25%
Beta 0.67
Analysts Sell
Price Target $103.13

Company Profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to fa...

Industry: Medical Devices
Sector: Healthcare
Phone: 574 373 3333
Address:
345 East Main Street, Warsaw, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:03 AM
$ZBH is currently trading at $89.91, showing a bearish market context with an RSI of 26.69, indicating oversold conditions. The stock is significantly below its 30-day moving average (MA30) of 97.27 and 50-day moving average (MA50) of 98.57, suggesting continued downward pressure. The recent 60-day high of 108.29 and low of 85.33 indicates a range that could be pivotal for future price action. Directional bias is bearish due to the RSI and the position below key moving averages. However, a potential reversal could occur if the price approaches the 60D low of 85.33. Suggested entry: $86.00 (if a reversal signal emerges). Stop loss: $84.00 (to limit downside). Target 1: $90.00 (near the MA30), Target 2: $95.00 (near the MA50). Monitor for signs of bullish momentum before entering. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
THUNDERMAN01
THUNDERMAN01 Nov. 14 at 12:33 PM
$ZBH - Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:37 AM
$ZBH is currently trading at $90.57, showing a bearish market context with an RSI of 27.56, indicating oversold conditions. The price is below both the 30-day MA of 97.63 and the 50-day MA of 98.88, reinforcing a downward trend. The recent high of $108.29 and low of $85.33 suggest a significant range, with the current price closer to the 60-day low. Directional bias is bearish due to the RSI indicating potential for further downside, but the oversold condition may lead to a short-term bounce. Suggested entry: $88.50, as a potential reversal point. Stop: $85.00 to limit losses in case of continued decline. Targets: $95.00 (near the 30-day MA) and $98.00 (near the 50-day MA) for potential profit-taking. Monitor price action closely for signs of reversal or continuation. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:43 AM
$ZBH trade plan: Market context shows a recent close at $88.65, significantly below both the 30-day moving average (MA30) of $98.22 and the 50-day moving average (MA50) of $99.47, indicating a bearish trend. The RSI at 21.06 suggests that the stock is oversold, which could lead to a potential reversal or a short-term bounce. The 60-day high of $108.29 and low of $85.33 further highlight the current price's proximity to the lower end of this range, suggesting limited downside risk. Directional bias is bearish in the long term but may see a corrective bounce in the short term due to the oversold RSI condition. Suggested entry: $89.00 (slightly above last close). Stop: $86.50 (below recent low). Targets: $92.00 (near MA30) and $95.00 (psychological resistance). Monitor for volatility with an ATR of 3.54, which could influence the stop placement. https://privateprofiteers.com
0 · Reply
doctordinero
doctordinero Nov. 12 at 4:35 PM
$ZTS and $ZBH are gonna move. $XLV GLTA
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:19 AM
$ZBH trade plan: Market context shows a recent close at $88.65, significantly below both the 30-day moving average (MA30) of $98.22 and the 50-day moving average (MA50) of $99.47, indicating a bearish trend. The RSI at 21.06 suggests that the stock is oversold, which could lead to a potential reversal or a short-term bounce. The 60-day high of $108.29 and low of $85.33 further highlight the current price's proximity to the lower end of this range, suggesting limited downside risk. Directional bias is bearish in the long term but may see a corrective bounce in the short term due to the oversold RSI condition. Suggested entry: $89.00 (slightly above last close). Stop: $86.50 (below recent low). Targets: $92.00 (near MA30) and $95.00 (psychological resistance). Monitor for volatility with an ATR of 3.54, which could influence the stop placement. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 8:39 PM
Canaccord Genuity updates rating for Zimmer Biomet Holdings ( $ZBH ) to Hold, target set at 101 → 93.
0 · Reply
Bear_Commander
Bear_Commander Nov. 9 at 7:42 PM
$ZBH Could maybe see a bounce here to $93
0 · Reply
pooldude44646
pooldude44646 Nov. 9 at 2:21 AM
$ZBH CEO surprised...really!? https://finance.yahoo.com/news/zimmer-ceo-very-surprised-q3-114330444.html
1 · Reply
jacob_morgan09
jacob_morgan09 Nov. 7 at 11:33 AM
$ZBH above $115, target $118.
0 · Reply
Latest News on ZBH
Time To Buy Zimmer Biomet Stock?

Nov 6, 2025, 11:15 AM EST - 8 days ago

Time To Buy Zimmer Biomet Stock?


Zimmer Biomet Announces Third Quarter 2025 Financial Results

Nov 5, 2025, 6:30 AM EST - 9 days ago

Zimmer Biomet Announces Third Quarter 2025 Financial Results


Zimmer Biomet Completes Acquisition of Monogram Technologies

Oct 7, 2025, 9:00 AM EDT - 5 weeks ago

Zimmer Biomet Completes Acquisition of Monogram Technologies


4 Stocks to Buy From a Top-Performing Fund Manager

Aug 12, 2025, 11:20 AM EDT - 3 months ago

4 Stocks to Buy From a Top-Performing Fund Manager

AMZN CRM NKE


Final Trades: Uber, Delta, Zimmer Holdings and Boeing

Jul 11, 2025, 2:21 PM EDT - 4 months ago

Final Trades: Uber, Delta, Zimmer Holdings and Boeing

BA UBER DAL


New vaccine panel meeting underway

Jun 26, 2025, 11:46 AM EDT - 5 months ago

New vaccine panel meeting underway

BDX BMY MRK UNH


Zimmer Biomet Announces First Quarter 2025 Financial Results

May 5, 2025, 6:30 AM EDT - 6 months ago

Zimmer Biomet Announces First Quarter 2025 Financial Results


Zimmer Biomet Completes Acquisition of Paragon 28

Apr 21, 2025, 9:00 AM EDT - 7 months ago

Zimmer Biomet Completes Acquisition of Paragon 28


PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:03 AM
$ZBH is currently trading at $89.91, showing a bearish market context with an RSI of 26.69, indicating oversold conditions. The stock is significantly below its 30-day moving average (MA30) of 97.27 and 50-day moving average (MA50) of 98.57, suggesting continued downward pressure. The recent 60-day high of 108.29 and low of 85.33 indicates a range that could be pivotal for future price action. Directional bias is bearish due to the RSI and the position below key moving averages. However, a potential reversal could occur if the price approaches the 60D low of 85.33. Suggested entry: $86.00 (if a reversal signal emerges). Stop loss: $84.00 (to limit downside). Target 1: $90.00 (near the MA30), Target 2: $95.00 (near the MA50). Monitor for signs of bullish momentum before entering. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
THUNDERMAN01
THUNDERMAN01 Nov. 14 at 12:33 PM
$ZBH - Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:37 AM
$ZBH is currently trading at $90.57, showing a bearish market context with an RSI of 27.56, indicating oversold conditions. The price is below both the 30-day MA of 97.63 and the 50-day MA of 98.88, reinforcing a downward trend. The recent high of $108.29 and low of $85.33 suggest a significant range, with the current price closer to the 60-day low. Directional bias is bearish due to the RSI indicating potential for further downside, but the oversold condition may lead to a short-term bounce. Suggested entry: $88.50, as a potential reversal point. Stop: $85.00 to limit losses in case of continued decline. Targets: $95.00 (near the 30-day MA) and $98.00 (near the 50-day MA) for potential profit-taking. Monitor price action closely for signs of reversal or continuation. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:43 AM
$ZBH trade plan: Market context shows a recent close at $88.65, significantly below both the 30-day moving average (MA30) of $98.22 and the 50-day moving average (MA50) of $99.47, indicating a bearish trend. The RSI at 21.06 suggests that the stock is oversold, which could lead to a potential reversal or a short-term bounce. The 60-day high of $108.29 and low of $85.33 further highlight the current price's proximity to the lower end of this range, suggesting limited downside risk. Directional bias is bearish in the long term but may see a corrective bounce in the short term due to the oversold RSI condition. Suggested entry: $89.00 (slightly above last close). Stop: $86.50 (below recent low). Targets: $92.00 (near MA30) and $95.00 (psychological resistance). Monitor for volatility with an ATR of 3.54, which could influence the stop placement. https://privateprofiteers.com
0 · Reply
doctordinero
doctordinero Nov. 12 at 4:35 PM
$ZTS and $ZBH are gonna move. $XLV GLTA
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:19 AM
$ZBH trade plan: Market context shows a recent close at $88.65, significantly below both the 30-day moving average (MA30) of $98.22 and the 50-day moving average (MA50) of $99.47, indicating a bearish trend. The RSI at 21.06 suggests that the stock is oversold, which could lead to a potential reversal or a short-term bounce. The 60-day high of $108.29 and low of $85.33 further highlight the current price's proximity to the lower end of this range, suggesting limited downside risk. Directional bias is bearish in the long term but may see a corrective bounce in the short term due to the oversold RSI condition. Suggested entry: $89.00 (slightly above last close). Stop: $86.50 (below recent low). Targets: $92.00 (near MA30) and $95.00 (psychological resistance). Monitor for volatility with an ATR of 3.54, which could influence the stop placement. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 8:39 PM
Canaccord Genuity updates rating for Zimmer Biomet Holdings ( $ZBH ) to Hold, target set at 101 → 93.
0 · Reply
Bear_Commander
Bear_Commander Nov. 9 at 7:42 PM
$ZBH Could maybe see a bounce here to $93
0 · Reply
pooldude44646
pooldude44646 Nov. 9 at 2:21 AM
$ZBH CEO surprised...really!? https://finance.yahoo.com/news/zimmer-ceo-very-surprised-q3-114330444.html
1 · Reply
jacob_morgan09
jacob_morgan09 Nov. 7 at 11:33 AM
$ZBH above $115, target $118.
0 · Reply
scientificway
scientificway Nov. 7 at 5:51 AM
$ZBH buy low. NAGE, rev eps up, guidance up, no debt. quick bounce
0 · Reply
lipmaz
lipmaz Nov. 6 at 11:46 PM
$ZBH we didn’t look that bad??
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 7:01 PM
UBS has adjusted their stance on Zimmer Biomet Holdings ( $ZBH ), setting the rating to Sell with a target price of 96 → 88.
0 · Reply
Robinurhood
Robinurhood Nov. 6 at 4:59 PM
Added $ZBH $SFM $ELF
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 4:33 PM
RBC Capital updates rating for Zimmer Biomet Holdings ( $ZBH ) to Outperform, target set at 111 → 101.
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 3:16 PM
Barclays has updated their rating for Zimmer Biomet Holdings ( $ZBH ) to Underweight with a price target of 104.
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 12:40 PM
JP Morgan has adjusted their stance on Zimmer Biomet Holdings ( $ZBH ), setting the rating to Neutral with a target price of 115 → 100.
0 · Reply
HarveyToronto
HarveyToronto Nov. 5 at 8:45 PM
$ZBH Arnold was promoting ZBH at the MedTech seminar back in Oct 2025 — that’s when I added it to my watchlist. Finally entered today. Patience always pays off.
0 · Reply
HarveyToronto
HarveyToronto Nov. 5 at 8:39 PM
I know $SYK is the better vs $ZBH. It has stronger growth, cleaner execution but $ZBH looks too cheap here based on fundamentals. Tempted to open a small position today by selling $85 puts and using the premium to buy $100 calls. If it bounces back after the post-earnings sell-off, the risk/reward looks solid.
0 · Reply
topstockalerts
topstockalerts Nov. 5 at 6:35 PM
Zimmer Biomet Is the S&P 500’s Worst Performer After Weak Sales Zimmer Biomet shares plunged 13% on Wednesday, marking their biggest one-day drop ever, after the maker of knee and hip implants reported weaker-than-expected quarterly results. The company posted adjusted earnings of $1.90 per share, slightly above estimates, but sales of $ 2 billion missed the $2.01 billion forecast. It also cut its full-year organic revenue growth outlook to 3.5%-4% from a prior 3.5%-4.5% range. Results were hurt by weak international performance—notably in Latin America, the Middle East, and Eastern Europe—along with distributor issues and canceled orders. Shares hit their lowest level since April 2020, making Zimmer Biomet the worst-performing stock in the S&P 500 for the day. $ZBH $SPX
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 6:12 PM
Barclays has updated their rating for Zimmer Biomet Holdings ( $ZBH ) to Underweight with a price target of 105.
0 · Reply
ZacksResearch
ZacksResearch Nov. 5 at 6:00 PM
$ZBH beats earnings but misses on revenue — market not happy. 📉 EPS came in above expectations, yet a revenue shortfall and lowered outlook are driving a pre-market drop. Full Q3 breakdown here 👉 https://www.zacks.com/stock/news/2785970/zimmer-biomet-q3-earnings-top-but-revenue-miss-causes-pre-market-drop?cid=sm-stocktwits-2-2785970-teaser-19687&ADID=SYND_STOCKTWITS_TWEET_2_2785970_TEASER_19687
0 · Reply